KLOX Technologies Announces European CE Mark Approval for its Innovative, Non-Invasive Acne Vulgaris Product
Laval, Quebec (ots/PRNewswire) - LumiCleanse[TM]is a clinically-proven treatment now available for all severities of acne vulgaris developed by KLOX in Canada, destined for the global acne market KLOX Technologies Inc. ("KLOX" or the "Company") is pleased to announce that it has received CE mark approval in Europe ...
mehr